Beauty

Shiseido Agrees to Sell Aupres Owner SLC to IDG-Led Group

Linnea NordvikNovember 19, 20265 min read0 views

At a glance

  • The binding agreement covers the Aupres maker and its Beijing factory, with completion expected between late 2026 and early 2027.
  • Shiseido has agreed to sell its Chinese subsidiary Shiseido Liyuan Cosmetics, which makes and sells Aupres, to a consortium led by IDG Capital, with closing expected between late 2026 and early 2027. The divestment is intended to improve profitability and capital efficiency, while Shiseido retains licensing and transitional support arrangements.
An unbranded cosmetic jar and bottle stand in a glass case between a laboratory bench and abstract manufacturing forms, linked by a lit pathway.

Shiseido has signed a binding agreement to sell its Chinese subsidiary, Shiseido Liyuan Cosmetics (SLC), to an investor group led by Hong Kong-based private equity firm IDG Capital. SLC manufactures and markets the Aupres brand in China. The transaction is expected to close between the fourth quarter of 2026 and the first quarter of 2027, subject to regulatory approvals including in China. Shiseido did not disclose the financial terms.

Shiseido links the sale to its 2030 Medium-Term Strategy, which aims to improve profitability and capital efficiency and to strengthen the group's competitiveness in China. The company says it intends to direct management resources toward businesses where it has the greatest competitive advantage. It describes China as a strategically important and dynamic market, but one where e-commerce expansion, changing consumer behavior and a more diverse set of competitors are reshaping the landscape. According to Shiseido, SLC requires continued investment in product innovation and digital capabilities; divesting the unit would allow the group to concentrate on priority brands and higher-growth opportunities.

SLC dates back to a 1991 joint venture with Beijing Liyuan, a subsidiary of Yiqing Group, which is owned by the Beijing Municipal Government. The company has sold Aupres, positioned as a C-beauty brand, since 1994. With the joint venture agreement due to expire in December 2026, the partners decided not to renew it. Shiseido said it acquired Beijing Liyuan's 35% stake on September 1, 2026, giving it full ownership before the sale.

Under the agreed structure, funds managed by IDG Capital will hold 95% of the equity through two special purpose vehicles. A limited partnership established mainly by SLC's incoming management team will hold the remaining 5%. The deal includes SLC's Beijing factory and production equipment. Shiseido argues that independent operation under IDG will support SLC's sustainable growth and brand value.

To smooth the handover, Shiseido will license the intellectual property rights that IDG needs to run the business. For a specified period after the transfer, Shiseido will also provide support on new product development, technical assistance to maintain stable supply of existing products, and continued supply of raw materials and selected products. These arrangements are meant to preserve SLC's innovation capabilities, product quality and business continuity.

The divestment was announced days after Shiseido reported a 124.3% increase in core operating profit for the third quarter of 2026, to ¥67.5 billion (US$422.13 million). The company attributed the improvement to restructuring, cost cuts and better margins rather than strong product demand; like-for-like sales rose 0.7%. Shiseido raised its full-year core operating profit forecast from ¥59 billion (US$433 million) to ¥87 billion (US$546 million).

Reported by Linnea Nordvik, Salon Equipment and Beauty Tools Writer.